Drug
Ferric derisomaltose clinical trials
Also written Monoferric.
- studies test it
- 32
- open now
- 22
- in phase 3
- 14
- first study started
- 2016
Keep track of what changes. Save the ferric derisomaltose studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
32 studies that test it; most in 2023 (9)
| Year | Studies |
|---|---|
| 2016 | 3 |
| 2017 | 3 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 14
- Phase 4
- 13
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 8 · Other 24
Pharmacosmos A/S (7) · China-Japan Friendship Hospital (3) · Massachusetts General Hospital (1) · Brigham and Women's Hospital (1) · Michael Kremke (1) · University of Glasgow (1) · Government of Jersey (1) · Duke University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ferric derisomaltose is read from its arms, and is right about nine times in ten.
Testing it · 32
- IV Iron Therapy for Older Adults With Heart Failure With Preserved Ejection Fraction and Iron DeficiencyNot yet recruitingPhase 4Duke UniversityNCT07686692Written as Ferric derisomaltose
- A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting ConditionsRecruitingPhase 1Sichuan Huiyu Pharmaceutical Co., LtdNCT07790562Written as Ferric Derisomaltose Injection
- Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart FailureRecruitingPhase 3Pharmacosmos A/SNCT06929806Written as Ferric Derisomaltose
- Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron DeficiencyEnrolling by invitationPhase 2Government of JerseyNCT07643818Written as Ferric Derisomaltose
- Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency AnemiaRecruitingPhase 3Pharmacosmos A/SNCT05179226Written as Ferric Derisomaltose
- IRONCARE: Iron Treatment in Older Patients With Hip FracturesNot yet recruitingPhase 4University of AarhusNCT07659184Written as Ferric Derisomaltose
- The Effects of Intravenous Iron on Mobility in Elderly Patients Following Hip Fracture SurgeryRecruitingPhase 4Soren OvergaardNCT06898814Written as Ferric Derisomaltose
- Intravenous Iron to Treat Postoperative Anemia in Older Cardiac Surgery PatientsRecruitingPhase 4dr. P. NoordzijNCT04913649Written as Ferric Derisomaltose 100 MG/ML
- Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac SurgeryRecruitingPhase 2University Health Network, TorontoNCT06287619Written as Monoferric Injectable Product
- Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac SurgeryNot yet recruitingPhase 4Yonsei UniversityNCT07238972Written as Ferric derisomaltose
- The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity SurgeryRecruitingPhase 4Peking Union Medical College HospitalNCT05714007Written as Ferric derisomaltose
- Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in PregnancyRecruitingPhase 3Women and Infants Hospital of Rhode IslandNCT05462704Written as Ferric derisomaltose
- Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in PregnancyRecruitingPhase 3Saskatchewan Health Authority - Regina AreaNCT05251493Written as Iron Isomaltoside 1000, ferric derisomaltose
- Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)RecruitingPhase 3AHS Cancer Control AlbertaNCT05407987Written as Ferric derisomaltose
- The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron DeficiencyRecruitingPhase 4China-Japan Friendship HospitalNCT06427343Written as High-dose ferric derisomaltose
- IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency DepartmentRecruitingPhase 3Baylor College of MedicineNCT05304442Written as Ferric Derisomaltose 1000 Mg in 10 mL INTRAVENOUS SOLUTION [Monoferric]
- Iron Deficiency Anemia (IDA) and the BrainRecruitingPhase 4Children's Hospital Los AngelesNCT05929729Written as Ferric derisomaltose
- Monoferric for Prenatal Iron DeficiencyRecruitingEarly Phase 1Oregon Health and Science UniversityNCT05763043Written as Ferric derisomaltose
- The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of LifeRecruitingPhase 4China-Japan Friendship HospitalNCT05991128Written as Ferric derisomaltose
- The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)RecruitingPhase 4China-Japan Friendship HospitalNCT05971732Written as Ferric derisomaltose
Codes
What other systems call ferric derisomaltose · ClinicalTrials.gg INT001646
- MeSH (NLM) C000718030ferric derisomaltoseConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) AHU547PI9HFERRIC DERISOMALTOSEConfirmed FDA, NLM
- RxNorm 2274394One source FDA
- NCI Thesaurus C171661Ferric DerisomaltoseOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000718030 | ferric derisomaltose | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | AHU547PI9H | FERRIC DERISOMALTOSE | Confirmed FDA, NLM |
| RxNorm | 2274394 | — | One source FDA |
| NCI Thesaurus | C171661 | Ferric Derisomaltose | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.